EURTAC first line therapy for non small cell lung carcinoma in epidermal growth factor receptor mutation positive patients: A choice between two TKIs
J Thorac Dis
.
2012 Apr 1;4(2):221-2.
doi: 10.3978/j.issn.2072-1439.2012.03.11.
Author
Barbara Melosky
1
Affiliation
1
British Columbia CancerAgency Vancouver Center, University of British Columbia, Vancouver, BC, Canada.
PMID:
22833833
PMCID:
PMC3378230
DOI:
10.3978/j.issn.2072-1439.2012.03.11
No abstract available